Thermo Fisher Scientific Inc.
TMO
$459.30
$6.701.48%
NYSE
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.85B | 6.70B | 6.57B | 6.58B | 6.51B |
| Total Depreciation and Amortization | 2.81B | 2.78B | 2.79B | 2.87B | 2.98B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 125.00M | 142.00M | -52.00M | -352.00M | -335.00M |
| Change in Net Operating Assets | -1.50B | -1.81B | -1.66B | -1.53B | -1.02B |
| Cash from Operations | 8.29B | 7.82B | 7.65B | 7.58B | 8.14B |
| Capital Expenditure | -1.54B | -1.53B | -1.54B | -1.41B | -1.42B |
| Sale of Property, Plant, and Equipment | 41.00M | 44.00M | 34.00M | 50.00M | 65.00M |
| Cash Acquisitions | -12.91B | -4.04B | -4.04B | -3.13B | -3.13B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.93B | 1.47B | 625.00M | 117.00M | 144.00M |
| Cash from Investing | -12.48B | -4.05B | -4.92B | -4.37B | -4.34B |
| Total Debt Issued | 11.64B | 8.85B | 3.94B | 2.84B | 2.84B |
| Total Debt Repaid | -4.08B | -3.51B | -4.72B | -5.23B | -4.45B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -4.00B | -3.00B | -3.96B | -3.00B | -3.00B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -649.00M | -636.00M | -623.00M | -610.00M | -597.00M |
| Other Financing Activities | 85.00M | 90.00M | -18.00M | 53.00M | 130.00M |
| Cash from Financing | 3.00B | 1.80B | -5.39B | -5.95B | -5.07B |
| Foreign Exchange rate Adjustments | 308.00M | 267.00M | 0.00 | 250.00M | -76.00M |
| Miscellaneous Cash Flow Adjustments | -2.00M | 0.00 | -1.00M | 0.00 | 1.00M |
| Net Change in Cash | -892.00M | 5.84B | -2.66B | -2.49B | -1.35B |